Sample size calculation for R-SABE [RSABE / ABEL]

posted by Lucas – Brazil, 2014-02-07 12:41 (4113 d 14:18 ago) – Posting: # 12362
Views: 18,782

Hi everybody.

ANVISA (Brazil's regulatory agency) is now studying the possibility of accepting EMA's method for scaling the BE acceptance interval based on the variability of the reference medication. So we are struggling a little bit in the sample size calculation, since it is very new to us. We have always used PASS for sample size calculation, for the standard BE studies, and did not manage to reproduce the results of PowerTOST calculations for RSABE. Is a whole different calculus? For example, when I try to calculate a sample size for a full replicate crossover design (TRTR, RTRT) considering a true ratio of 0.95, a target power of 80% and a reference ISCV of 63%, in PASS I got 28 subjects (considering the equivalence limits of 69.84%–143.19%) and in PowerTOST I got 22 subjects.
Can you guys help me with that? Should I throw away my PASS? :confused:


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
166 visitors (0 registered, 166 guests [including 9 identified bots]).
Forum time: 03:59 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5